Glycomacropeptide Ameliorates Indomethacin-Induced Enteropathy in Rats by Modifying Intestinal Inflammation and Oxidative Stress

Glycomacropeptide Ameliorates Indomethacin-Induced Enteropathy in Rats by Modifying Intestinal Inflammation and Oxidative Stress

Nonsteroidal anti-inflammatory drug (NSAID)-induced enteropathy is considered a serious and increasing clinical problem without available treatment. Glycomacropeptide (GMP) is a 64-amino acid peptide derived from milk κ-casein with numerous biological activities. The aim of this study was to investi...

Full description

Bibliographic Details
Main Authors: Daniel Cervantes-García, Armida I. Bahena-Delgado, Mariela Jiménez, Laura E. Córdova-Dávalos, Vanessa Ruiz-Esparza Palacios, Esperanza Sánchez-Alemán, María C. Martínez-Saldaña, Eva Salinas
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Molecules
Subjects:
nonsteroidal anti-inflammatory drugs
intestinal damage
glycomacropeptide
neutrophil infiltration
inflammatory mediators
oxidative damage
Online Access:https://www.mdpi.com/1420-3049/25/10/2351

Internet

https://www.mdpi.com/1420-3049/25/10/2351

Similar Items